Primary Care Diabetes
Volume 3, Issue 3 , Pages 131-139 , August 2009

Hypoglycaemia: An overview

Received 20 April 2009 ,Revised 17 August 2009 ,Accepted 25 August 2009.

References 

  1. The Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986
  2. DCCT/EDIC Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 2005;353:2643–2653
  3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  4. Holman RR, Paul SK, Bethel AB. 10-Year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008;359:1577–1589
  5. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57:3169–3176
  6. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 1991;8:217–222
  7. Frier BM. Defining hypoglycaemia: what level has clinical relevance?. Diabetologia. 2009;52:31–34
  8. Cryer PE. Preventing hypoglycaemia: what is the appropriate glucose alert value?. Diabetologia. 2009;52:35–37
  9. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, et al. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia. 2003;46:89–96
  10. Swinnen SGH, Mullins P, Miller M, Hoekstra JBL, Holleman F. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia. 2008;52:38–41
  11. Strachan MWJ. Frequency causes and risk factors for hypoglycaemia in type 1 diabetes. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley & Sons; 2007;p. 49–82
  12. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140–1147
  13. Pedersen-Bjergaard U, Pramming S, Heller SR, et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 2004;20:479–486
  14. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet. Med. 2003;20:1016–1021
  15. Leiter LA, Yale J, Chiasson J, et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can. J. Diabetes. 2005;29:186–192
  16. Donnelly LA, Morris AD, Frier BM, et al. for the DARTS/MEMO Collaboration Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet. Med. 2005;22:749–755
  17. McAulay V, Frier BM, Hypoglycaemia . In:  Sinclair AJ editors. Diabetes in Old Age. 3rd ed.. Chichester: John Wiley & Sons; 2009;p. 287–310
  18. Caplin NJ, O’Leary P, Bulsara M, et al. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet. Med. 2003;20:238–241
  19. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003;26:1153–1157
  20. Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Reproducibility and reliability of hypoglycaemic episodes recorded with continuous glucose monitoring system (CGMS) in daily life. Diabet. Med. 2005;22:858–862
  21. Guillod L, Comte-Perret S, Monbaron D, et al. Nocturnal hypoglycaemia in type 1 diabetic patients: what can we learn with continuous glucose monitoring?. Diabetes Metab. 2007;33:360–365
  22. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia. 1993;36:771–777
  23. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet. Med. 2001;18:690–705
  24. Deary IJ. Symptoms of hypoglycaemia and effects on mental performance and emotions. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley & Sons; 2007;p. 25–48
  25. Airey CM, Williams DRR, Martin PG, et al. Hypoglycaemia induced by exogenous insulin—‘human’ and animal insulin compared. Diabet. Med. 2000;17:416–432
  26. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor?. Diabetes Metab. Res. Rev. 2008;24:353–363
  27. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 2008;358:2545–2559
  28. Bloomgarden ZT. Glycemic control in diabetes: a tale of three studies. Diabetes Care. 2008;31:1913–1919
  29. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009;360:1283–1297
  30. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association cohort study II: cause specific mortality in patients with insulin-treated diabetes mellitus. Diabet. Med. 1999;16:466–471
  31. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet. Med. 1991;8:49–50
  32. Robinson RT, Harris ND, Ireland RH, et al. Mechanisms of abnormal cardiac repolarisation during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–1474
  33. Koivikko ML, Karikas M, Salmela PI, Tapanainen JS, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51:426–435
  34. Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia. Diabetes Care. 2003;26:1485–1489
  35. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet. Med. 1993;10:238–245
  36. Perros P, Deary IJ. Long-term effects of hypoglycaemia on cognitive function and the brain in diabetes. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley & Sons; 2007;p. 285–307
  37. Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135–141
  38. Zammitt NN, Warren RE, Deary IJ, Frier BM. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes. Diabetes. 2008;57:732–736
  39. DCCT/EDIC . Long-term effect of diabetes and its treatment of cognitive function. N. Engl. J. Med. 2007;356:1842–1852
  40. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7:184–190
  41. Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ. Couns. 2007;68:10–15
  42. Jorgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care. 2003;26:1106–1109
  43. McCrimmon RJ, Frier BM, Deary IJ. Appraisal of mood and personality during hypoglycaemia in human subjects. Physiol. Behav. 1999;67:27–33
  44. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54:3592–3601
  45. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Diabetes Care. 2005;28:2948–2961
  46. Hepburn DA, Deary IJ, Frier BM. Classification of symptoms of hypoglycaemia in insulin-treated diabetic patients using factor analysis: relationship to hypoglycaemia unawareness. Diabet. Med. 1992;9:70–75
  47. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697–703
  48. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 2008;25:501–504
  49. Clarke WL, Cox DJ, Gonder-Frederick LA, et al. Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517–522
  50. Geddes J, Wright RJ, Zammitt NN, et al. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care. 2007;30:1868–1870
  51. Boyle PJ, Nagy RJ, O’Connor AM, et al. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc. Natl. Acad. Sci. U.S.A. 1994;91:9352–9356
  52. Frier BM. Impaired awareness of hypoglycaemia. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley & Sons; 2007;p. 141–170
  53. Heller SR. Minimizing hypoglycemia while maintaining glycemic control in diabetes. Diabetes. 2008;57:3177–3183
  54. Hovarth K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2007;Art. No. CD005613
  55. Jeitler K, Hovarth K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia. 2008;51:941–951
  56. National Institute for Health and Clinical Excellence . Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. 2008;http://www.nice.org.uk/Guidance/TA151
  57. Richardson T, Kerr D. Moderators, monitoring and management of hypoglycaemia. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley & Sons; 2007;p. 101–120
  58. Richardson T, Weiss M, Thomas P, Kerr D. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2005;28:1801–1802
  59. Debrah K, Sherwin RS, Murphy J, Kerr D. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. Lancet. 1996;347:19–24
  60. Richardson T, Thomas P, Ryder J, Kerr D. Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. Diabetes Care. 2005;28:1316–1320
  61. Muhlhauser U, Bruckner I, Berger M, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of Type 1 (insulin-dependent) diabetes. Diabetologia. 1987;30:681–690
  62. Samann A, Muhlhauser I, Bender R, et al. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia. 2005;48:1965–1970
  63. Cox DJ, Kovatchev B, Koev D, et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int. J. Behav. Med. 2004;11:212–218
  64. Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. Progressive hypoglycemia's impact on driving simulation performance, occurrence, awareness and correction. Diabetes Care. 2000;23:163–170
  65. Stork ADM, van Haeften TW, Veneman TF. Diabetes and driving: desired data, research methods and their pitfalls, current knowledge and future research. Diabetes Care. 2006;29:1942–1949
  66. Graveling AJ, Warren RE, Frier BM. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. Diabet. Med. 2004;21:1014–1019
  67. DVLA . At a Glance Guide to the Current Medical Standards of Fitness to Drive. 2009;http://www.dvla.gov.uk/media/pdf/medical/aagv1.pdf
  68. Diabetes UK . Driving and Diabetes. 2008;https://www.diabetes.org.uk/upload/Driving_Diabetes_9044.pdf
  69. Waclawski ER, Gill GV, Diabetes . Mellitus and other endocrine disorders. In:  Palmer KT,  Cox RAF,  Brown I editor. Fitness for Work: the Medical Aspects. 4th ed.. Oxford: Oxford University Press; 2007;p. 345–360
  70. Leckie AM, Graham MK, Grant JB, et al. Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes. Diabetes Care. 2005;28:1333–1338
  71. Frier BM. Living with hypoglycaemia. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley & Sons; 2007;p. 309–332
  72. Peirce NS. Diabetes and exercise. Br. J. Sports Med. 1999;33:161–173
  73. Brazeau A, Rabasa-Lohret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care. 2008;31:2108–2109
  74. MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care. 1987;10:584–588
  75. Perry E, Gallen IW. Guidelines on the current best practice for the management of type 1 diabetes, sport and exercise. Pract. Diab. Int. 2009;26:116–123
  76. MacCuish AC. Treatment of Hypoglycaemia. In:  Frier BM,  Fisher BM editor. Hypoglycaemia and Diabetes, Clinical and Physiological Aspects. London: Edward Arnold; 1993;p. 212–221

PII: S1751-9918(09)00087-4

doi: 10.1016/j.pcd.2009.08.007

Primary Care Diabetes
Volume 3, Issue 3 , Pages 131-139 , August 2009

Article Tools

* Image Usage & Resolution